Coxsackievirus A9 VP1 Mutants with Enhanced or Hindered A Particle Formation and Decreased Infectivity
Open Access
- 15 January 2001
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (2) , 952-960
- https://doi.org/10.1128/jvi.75.2.952-960.2001
Abstract
We have studied coxsackievirus A9 (CAV9) mutants that each have a single amino acid substitution in the conserved 29-PALTAVETGHT-39 motif of VP1 and a reduced capacity to produce infectious progeny virus. After uncoating, all steps in the infection cycle occurred according to the same kinetics as and similar efficiency to the wild-type virus. However, the particle/infectious unit ratio in the progeny was significantly increased. The differences were apparently due to altered stability of the capsid: there were mutant viruses with enhanced or hindered uncoating, and both of these characteristics were found to reduce fitness under standard passaging conditions. At 32°C the instable mutants had an advantage, while the wild-type and the most stable mutant grew poorly. When comparing the newly published CAV9 structure and the other enterovirus structures, we found that the PALTAVETGHT motif is always in exactly the same position, in a cavity formed by the 3 other capsid proteins, with the C terminus of VP4 between this motif and the RNA. In the 7 enterovirus structures determined to date, the most conserved residues of the studied motif have identical contacts to neighboring residues of VP2, VP3, and VP4. We conclude that (i) the mutations affect the uncoating step necessary for infection, resulting in an untimely or hindered externalization of the VP1 N terminus together with the VP4, and (ii) the reason for the studied motif being evolutionarily conserved is its role in maintaining an optimal balance between the protective stability and the functional flexibility of the capsid.Keywords
This publication has 22 references indexed in Scilit:
- The refined structure of human rhinovirus 16 at 2.15 Å resolution: implications for the viral life cycleStructure, 1997
- Efficient RGD-independent entry process of coxsackievirus A9Archiv für die gesamte Virusforschung, 1996
- Human rhinovirus 3 at 3.0 å resolutionStructure, 1996
- The structure of coxsackievirus B3 at 3.5 å resolutionStructure, 1995
- Implications for viral uncoating from the structure of bovine enterovirusNature Structural & Molecular Biology, 1995
- Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: Structure of the empty capsid assembly intermediate at 2.9 Å resolutionProtein Science, 1994
- The Nucleotide Sequence of Coxsackievirus A9; Implications for Receptor Binding and Enterovirus ClassificationJournal of General Virology, 1989
- Crystal structure of human rhinovirus serotype 1A (HRV1A)Journal of Molecular Biology, 1989
- The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structureActa Crystallographica Section A Foundations of Crystallography, 1988
- Three-Dimensional Structure of Poliovirus at 2.9 Å ResolutionScience, 1985